According to Cosmo Pharmaceuticals's latest financial reports the company's current earnings (TTM) are A$39.02 M. In 2022 the company made an earning of A$39.02 M a decrease over its 2021 earnings that were of A$40.4 M.The earnings displayed on this page is the company's Pretax Income.